World's Best Scientists 2026 revealed!
Cheryl A. London

Cheryl A. London

D-Index & Metrics

Biology and Biochemistry

D-Index
51
Citations
10138
World Ranking
17115
National Ranking
7052

Overview

Cheryl A. London is affiliated with Tufts University in the United States and conducts research primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans several subfields, including Pulmonary and Respiratory Medicine, Molecular Biology, Genetics, Oncology, and Cardiology and Cardiovascular Medicine.

The scientist's research covers multiple main topics, with a strong focus on Veterinary Oncology Research, Virus-based gene therapy research, Sarcoma Diagnosis and Treatment, Chemotherapy-induced cardiotoxicity and mitigation, Cancer Research and Treatments, Infectious Diseases and Mycology, and Angiogenesis and VEGF in Cancer.

Cheryl A. London has published numerous papers in a variety of journals. Some of the more recent publications include:

  • "VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications" (2022), published in Current Oncology Reports
  • "Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs" (2021), published in Clinical Cancer Research
  • "Cytotoxic T cells drive doxorubicin-induced cardiac fibrosis and systolic dysfunction" (2024), published in Nature Cardiovascular Research
  • "Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force" (2021), published in Pediatric Blood & Cancer
  • "Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma" (2023), published in Veterinary and Comparative Oncology

Frequent co-authors appearing in collaboration with Cheryl A. London include Heather L. Gardner, Vicky K. Yang, Iris Z. Jaffe, Kate Megquier, and Jenica Upshaw.

The most common publication venues where this scientist's work appears are Veterinary and Comparative Oncology, PLoS ONE, bioRxiv (Cold Spring Harbor Laboratory), Circulation, and Clinical Cancer Research.

Best Publications

  • Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document

    S. M. Nguyen;D. H. Thamm;D. M. Vail;C. A. London

  • The dog as a cancer model.

    Chand Khanna;Kerstin Lindblad-Toh;David Vail;Cheryl London

  • Feline lymphoma in the post-feline leukemia virus era

    Mathilde Louwerens;Cheryl A. London;Niels C. Pedersen;Leslie A. Lyons

  • Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.

    Joelle M Fenger;Cheryl A London;William C Kisseberth

  • Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours

    Cheryl London;Tamra Mathie;Nicole Stingle;Craig Clifford

  • Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)--a Veterinary Cooperative Oncology Group (VCOG) consensus document.

    D. M. Vail;G. M. Michels;C. Khanna;K. A. Selting

  • Dogs as a Model for Cancer

    Heather L. Gardner;Joelle M. Fenger;Cheryl A. London

  • Tyrosine kinase inhibitors in veterinary medicine.

    Cheryl A. London

  • Lomustine (CCNU) for the Treatment of Resistant Lymphoma in Dogs

    Antony S. Moore;Cheryl A. London;Carrie A. Wood;Laurel E. Williams

  • Genome-wide analyses implicate 33 loci in heritable dog osteosarcoma, including regulatory variants near CDKN2A/B

    Elinor K Karlsson;Elinor K Karlsson;Snaevar Sigurdsson;Snaevar Sigurdsson;Emma Ivansson;Emma Ivansson;Rachael Thomas

  • The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors.

    Tzu-Yin Lin;Misty Bear;Zhenjian Du;Kevin P. Foley

  • Characterization of STAT3 activation and expression in canine and human osteosarcoma.

    Stacey L Fossey;Albert T Liao;Jennifer K McCleese;Misty D Bear

  • Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines

    Stacey L Fossey;Misty D Bear;William C Kisseberth;Michael Pennell

  • Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma

    D M Vail;W C Kisseberth;J E Obradovich;F M Moore

  • Guiding the Optimal Translation of New Cancer Treatments From Canine to Human Cancer Patients

    Chand Khanna;Cheryl London;David Vail;Christina Mazcko

  • Comparison of COAP and UW‐19 Protocols for Dogs with Multicentric Lymphoma

    Kenji Hosoya;William C. Kisseberth;Linda K. Lord;Francisco J. Alvarez

  • Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study

    Cheryl A. London;Luis Feo Bernabe;Sandra Barnard;William C. Kisseberth

  • Perspectives from man’s best friend: National Academy of Medicine’s Workshop on Comparative Oncology

    Amy K. LeBlanc;Matthew Breen;Peter Choyke;Mark Dewhirst

  • The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines

    Stacey L Fossey;Misty D Bear;Jiayuh Lin;Chenglong Li

  • Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose

    Luis Feo Bernabe;Roberta Portela;Sandra Nguyen;William C Kisseberth

Frequent Co-Authors

Peter J. Houghton
Peter J. Houghton The University of Texas Health Science Center at San Antonio
Jaime F. Modiano
Jaime F. Modiano University of Minnesota
Denis C. Guttridge
Denis C. Guttridge Medical University of South Carolina
Matthew Breen
Matthew Breen North Carolina State University
Kerstin Lindblad-Toh
Kerstin Lindblad-Toh Uppsala University
William E. Carson
William E. Carson The Ohio State University
Ching-Shih Chen
Ching-Shih Chen The Ohio State University
Stefano Volinia
Stefano Volinia University of Ferrara
Elinor K. Karlsson
Elinor K. Karlsson Broad Institute
John C. Byrd
John C. Byrd University of Pittsburgh Cancer Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Biology or Biochemistry can open doors to a wide range of opportunities in healthcare and science. Many professionals choose to start with practical roles, such as training through an online medical assisting school for hands-on patient care experience. This path is ideal for those seeking a fast entry into the job market and foundational skills for further advancement.

For medical assistants who wish to expand their scope of practice, cma to lpn bridge programs online provide a streamlined route to become Licensed Practical Nurses. This step can lead to greater responsibility and higher earning potential in clinical settings.

Students interested in deeper scientific study often pursue a bs in biology online. Accelerated and online formats offer flexibility, making it easier to balance studies with work or personal commitments.

If you're aiming for nursing, an asn online can quickly prepare you for the NCLEX and a rewarding career in patient care. This is a popular path for those who want a focused, career-oriented degree in the life sciences.

Best Scientists Citing Cheryl A. London

Trending Scientists

Recently Published Articles